{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:21:38Z","timestamp":1789042898045,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46213-6","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:48:35Z","timestamp":1774957715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrative immunogenomic strategy for designing a multi-epitope vaccine against Zika and Dengue viruses"],"prefix":"10.1038","volume":"16","author":[{"given":"Akmal","family":"Zubair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed","family":"Aldehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Yaqoob","family":"Shahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Afghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"46213_CR1","doi-asserted-by":"crossref","unstructured":"Chappell, J. D. & Dermody, T. S. Biology of viruses and viral diseases. Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases, : p. 1681. (2014).","DOI":"10.1016\/B978-1-4557-4801-3.00134-X"},{"issue":"7446","key":"46213_CR2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt, S. et al. The global distribution and burden of dengue. Nature 496 (7446), 504\u2013507 (2013).","journal-title":"Nature"},{"issue":"6","key":"46213_CR3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1473-3099(16)00095-5","volume":"16","author":"G Calvet","year":"2016","unstructured":"Calvet, G. et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect. Dis. 16 (6), 653\u2013660 (2016).","journal-title":"Lancet Infect. Dis."},{"issue":"7","key":"46213_CR4","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S1473-3099(16)30010-X","volume":"16","author":"N Wikan","year":"2016","unstructured":"Wikan, N. & Smith, D. R. Zika virus: history of a newly emerging arbovirus. Lancet Infect. Dis. 16 (7), e119\u2013e126 (2016).","journal-title":"Lancet Infect. Dis."},{"issue":"16","key":"46213_CR5","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1128\/JVI.75.16.7290-7304.2001","volume":"75","author":"F Guirakhoo","year":"2001","unstructured":"Guirakhoo, F. et al. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J. Virol. 75 (16), 7290\u20137304 (2001).","journal-title":"J. Virol."},{"issue":"12","key":"46213_CR6","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","volume":"74","author":"F Guirakhoo","year":"2000","unstructured":"Guirakhoo, F. et al. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J. Virol. 74 (12), 5477\u20135485 (2000).","journal-title":"J. Virol."},{"issue":"9","key":"46213_CR7","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","volume":"78","author":"F Guirakhoo","year":"2004","unstructured":"Guirakhoo, F. et al. Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates. J. Virol. 78 (9), 4761\u20134775 (2004).","journal-title":"J. Virol."},{"issue":"2","key":"46213_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1411037","volume":"372","author":"L Villar","year":"2015","unstructured":"Villar, L. et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl. J. Med. 372 (2), 113\u2013123 (2015).","journal-title":"N Engl. J. Med."},{"issue":"13","key":"46213_CR9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","volume":"373","author":"SR Hadinegoro","year":"2015","unstructured":"Hadinegoro, S. R. et al. Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. N Engl. J. Med. 373 (13), 1195\u20131206 (2015).","journal-title":"N Engl. J. Med."},{"issue":"12","key":"46213_CR10","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1038\/cti.2016.72","volume":"5","author":"LM Paul","year":"2016","unstructured":"Paul, L. M. et al. Dengue virus antibodies enhance Zika virus infection. Clin. Transl Immunol. 5 (12), e117 (2016).","journal-title":"Clin. Transl Immunol."},{"issue":"28","key":"46213_CR11","doi-asserted-by":"publisher","first-page":"7852","DOI":"10.1073\/pnas.1607931113","volume":"113","author":"L Priyamvada","year":"2016","unstructured":"Priyamvada, L. et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc. Natl. Acad. Sci. U S A. 113 (28), 7852\u20137857 (2016).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"5","key":"46213_CR12","first-page":"781","volume":"215","author":"PMS Castanha","year":"2017","unstructured":"Castanha, P. M. S. et al. Dengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection. J. Infect. Dis. 215 (5), 781\u2013785 (2017).","journal-title":"J. Infect. Dis."},{"issue":"9","key":"46213_CR13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","volume":"17","author":"W Dejnirattisai","year":"2016","unstructured":"Dejnirattisai, W. et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat. Immunol. 17 (9), 1102\u20131108 (2016).","journal-title":"Nat. Immunol."},{"issue":"1","key":"46213_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/vim.2008.0063","volume":"22","author":"L Gil","year":"2009","unstructured":"Gil, L. et al. The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis model. Viral Immunol. 22 (1), 23\u201330 (2009).","journal-title":"Viral Immunol."},{"issue":"5","key":"46213_CR15","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/JVI.02675-12","volume":"87","author":"L Rivino","year":"2013","unstructured":"Rivino, L. et al. Differential targeting of viral components by CD4\u2009+\u2009versus CD8\u2009+\u2009T lymphocytes in dengue virus infection. J. Virol. 87 (5), 2693\u20132706 (2013).","journal-title":"J. Virol."},{"issue":"6","key":"46213_CR16","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00705-013-1618-6","volume":"158","author":"T Yoshida","year":"2013","unstructured":"Yoshida, T. et al. Dynamics of cellular immune responses in the acute phase of dengue virus infection. Arch. Virol. 158 (6), 1209\u20131220 (2013).","journal-title":"Arch. Virol."},{"issue":"1","key":"46213_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1128\/JVI.02129-14","volume":"89","author":"D Weiskopf","year":"2015","unstructured":"Weiskopf, D. et al. The human CD8\u2009+\u2009T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J. Virol. 89 (1), 120\u2013128 (2015).","journal-title":"J. Virol."},{"key":"46213_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.virol.2015.10.006","volume":"487","author":"JH Amorim","year":"2016","unstructured":"Amorim, J. H. et al. Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model. Virology 487, 41\u201349 (2016).","journal-title":"Virology"},{"issue":"6","key":"46213_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1128\/CVI.00081-16","volume":"23","author":"R Alves","year":"2016","unstructured":"Alves, R. et al. Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen. Clin. Vaccine Immunol. 23 (6), 460\u2013469 (2016).","journal-title":"Clin. Vaccine Immunol."},{"issue":"Web Server issu","key":"46213_CR20","doi-asserted-by":"publisher","first-page":"pW72","DOI":"10.1093\/nar\/gki396","volume":"33","author":"J Cheng","year":"2005","unstructured":"Cheng, J. et al. SCRATCH: a protein structure and structural feature prediction server. Nucleic Acids Res. 33 (Web Server issue), pW72\u2013pW76 (2005).","journal-title":"Nucleic Acids Res."},{"issue":"17\u201318","key":"46213_CR21","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.vaccine.2005.01.031","volume":"23","author":"A Yano","year":"2005","unstructured":"Yano, A. et al. An ingenious design for peptide vaccines. Vaccine 23 (17\u201318), 2322\u20132326 (2005).","journal-title":"Vaccine"},{"key":"46213_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8, 4 (2007).","journal-title":"BMC Bioinform."},{"issue":"9","key":"46213_CR23","doi-asserted-by":"publisher","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta, S. et al. In silico approach for predicting toxicity of peptides and proteins. PLoS One. 8 (9), e73957 (2013).","journal-title":"PLoS One"},{"key":"46213_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.future.2019.04.011","volume":"99","author":"W Zheng","year":"2019","unstructured":"Zheng, W. et al. I-TASSER gateway: A protein structure and function prediction server powered by XSEDE. Future Gener Comput. Syst. 99, 73\u201385 (2019).","journal-title":"Future Gener Comput. Syst."},{"issue":"Suppl 8","key":"46213_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/prot.21702","volume":"69","author":"Y Zhang","year":"2007","unstructured":"Zhang, Y. Template-based modeling and free modeling by I-TASSER in CASP7. Proteins 69 (Suppl 8), 108\u2013117 (2007).","journal-title":"Proteins"},{"key":"46213_CR26","doi-asserted-by":"crossref","unstructured":"Blankenberg, D. et al. Galaxy: a web-based genome analysis tool for experimentalists. Curr Protoc Mol Biol. Chapter 19, p. Unit 19.10.1\u201321. (2010).","DOI":"10.1002\/0471142727.mb1910s89"},{"issue":"Web Server issu","key":"46213_CR27","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein, M. & Sippl, M. J. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 35 (Web Server issue), W407\u2013W410 (2007).","journal-title":"Nucleic Acids Res."},{"key":"46213_CR28","unstructured":"Zobayer, M. N. In silico characterization and homology modeling of histamine receptors (Khulna University of Engineering & Technology (KUET), Khulna, 2019)."},{"issue":"4","key":"46213_CR29","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin, N. et al. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One. 5 (4), e9862 (2010).","journal-title":"PLoS One"},{"key":"46213_CR30","doi-asserted-by":"publisher","first-page":"104420","DOI":"10.1016\/j.compbiomed.2021.104420","volume":"133","author":"A Khan","year":"2021","unstructured":"Khan, A. et al. Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation. Comput. Biol. Med. 133, 104420 (2021).","journal-title":"Comput. Biol. Med."},{"issue":"2","key":"46213_CR31","doi-asserted-by":"publisher","first-page":"010312","DOI":"10.7189\/jogh.08.020312","volume":"8","author":"K Fatima","year":"2018","unstructured":"Fatima, K. & Syed, N. I. Dengvaxia controversy: impact on vaccine hesitancy. J. Glob Health. 8 (2), 010312 (2018).","journal-title":"J. Glob Health"},{"issue":"2","key":"46213_CR32","first-page":"1","volume":"13","author":"KP Mendoza","year":"2020","unstructured":"Mendoza, K. P. Vaccine hesitancy and the cultural politics of Trust in the Dengvaxia Controversy: a critical discourse-ethnographic study of online news content, producers, and audiences. ASEAS-Austrian J. South-East Asian Stud. 13 (2), 1\u20138 (2020).","journal-title":"ASEAS-Austrian J. South-East Asian Stud."},{"issue":"10","key":"46213_CR33","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1080\/21645515.2019.1658503","volume":"15","author":"SJ Thomas","year":"2019","unstructured":"Thomas, S. J. & Yoon, I. K. A review of Dengvaxia\u00ae: development to deployment. Hum. Vaccin Immunother. 15 (10), 2295\u20132314 (2019).","journal-title":"Hum. Vaccin Immunother"},{"issue":"2","key":"46213_CR34","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s10989-020-10144-1","volume":"27","author":"S Rahmat Ullah","year":"2021","unstructured":"Rahmat Ullah, S. et al. Immunoinformatics Driven Prediction of Multiepitopic Vaccine Against Klebsiella pneumoniae and Mycobacterium tuberculosis Coinfection and Its Validation via In Silico Expression. Int. J. Pept. Res. Ther. 27 (2), 987\u2013999 (2021).","journal-title":"Int. J. Pept. Res. Ther."},{"key":"46213_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.compbiolchem.2016.04.006","volume":"62","author":"N Nezafat","year":"2016","unstructured":"Nezafat, N. et al. Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches. Comput. Biol. Chem. 62, 82\u201395 (2016).","journal-title":"Comput. Biol. Chem."},{"key":"46213_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ijbiomac.2020.04.097","volume":"156","author":"R Ojha","year":"2020","unstructured":"Ojha, R., Pandey, R. K. & Prajapati, V. K. Vaccinomics strategy to concoct a promising subunit vaccine for visceral leishmaniasis targeting sandfly and leishmania antigens. Int. J. Biol. Macromol. 156, 548\u2013557 (2020).","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"46213_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2174\/1871526519666190521100521","volume":"20","author":"MH Jadoon","year":"2020","unstructured":"Jadoon, M. H. et al. In silico T-cell and B-cell Epitope Based Vaccine Design Against Alphavirus Strain of Chikungunya. Infect. Disord Drug Targets. 20 (4), 523\u2013530 (2020).","journal-title":"Infect. Disord Drug Targets"},{"key":"46213_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2019.02.001","volume":"59","author":"J Wen","year":"2019","unstructured":"Wen, J. & Shresta, S. Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine? Curr. Opin. Immunol. 59, 1\u20138 (2019).","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"46213_CR39","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41467-019-14115-z","volume":"11","author":"P Sun","year":"2020","unstructured":"Sun, P. et al. A mosquito salivary protein promotes flavivirus transmission by activation of autophagy. Nat. Commun. 11 (1), 260 (2020).","journal-title":"Nat. Commun."},{"key":"46213_CR40","doi-asserted-by":"publisher","unstructured":"Hastings, A. K. et al. Aedes aegypti NeSt1 protein enhances Zika virus pathogenesis by activating neutrophils. J. Virol. 93 (13). https:\/\/doi.org\/10.1128\/jvi (2019). 00395\u2009\u2013\u200919.","DOI":"10.1128\/jvi"},{"issue":"47","key":"46213_CR41","doi-asserted-by":"publisher","first-page":"18631","DOI":"10.1073\/pnas.0702130104","volume":"104","author":"N Funderburg","year":"2007","unstructured":"Funderburg, N. et al. Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc. Natl. Acad. Sci. U S A. 104 (47), 18631\u201318635 (2007).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"46213_CR42","doi-asserted-by":"publisher","first-page":"813047","DOI":"10.1155\/2015\/813047","volume":"2015","author":"JE Mu\u00f1oz-Medina","year":"2015","unstructured":"Mu\u00f1oz-Medina, J. E. et al. In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination Potential. Biomed. Res. Int. 2015, 813047 (2015).","journal-title":"Biomed. Res. Int."},{"key":"46213_CR43","first-page":"402492","volume":"2014","author":"MS Sakib","year":"2014","unstructured":"Sakib, M. S. et al. Prediction of epitope-based peptides for the utility of vaccine development from fusion and glycoprotein of nipah virus using in silico approach. Adv. Bioinf. 2014, 402492 (2014).","journal-title":"Adv. Bioinf."},{"key":"46213_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2105-15-161","volume":"15","author":"R Sharmin","year":"2014","unstructured":"Sharmin, R. & Islam, A. B. A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitope-based universal vaccine design. BMC Bioinform. 15, 161 (2014).","journal-title":"BMC Bioinform."},{"issue":"1","key":"46213_CR45","first-page":"813047","volume":"2015","author":"JE Mu\u00f1oz-Medina","year":"2015","unstructured":"Mu\u00f1oz-Medina, J. E. et al. In silico identification of highly conserved epitopes of influenza A H1N1, H2N2, H3N2, and H5N1 with diagnostic and vaccination potential. Biomed. Res. Int. 2015 (1), 813047 (2015).","journal-title":"Biomed. Res. Int."},{"key":"46213_CR46","doi-asserted-by":"crossref","unstructured":"See, K. C. Dengue Vaccination: A Practical Guide for Clinicians. Vaccines (Basel), 13(2) (2025).","DOI":"10.3390\/vaccines13020145"},{"issue":"8","key":"46213_CR47","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1080\/14760584.2020.1794832","volume":"19","author":"K Kardani","year":"2020","unstructured":"Kardani, K., Bolhassani, A. & Namvar, A. An overview of in silico vaccine design against different pathogens and cancer. Expert Rev. Vaccines. 19 (8), 699\u2013726 (2020).","journal-title":"Expert Rev. Vaccines"},{"key":"46213_CR48","doi-asserted-by":"crossref","unstructured":"Slathia, P. S. & Sharma, P. In Silico Designing of Vaccines: Methods, Tools, and Their Limitations, in Computer-Aided Drug Design, (Ed. Singh, D. B.) pp. 245\u2013277. (Springer Singapore: Singapore, 2020).","DOI":"10.1007\/978-981-15-6815-2_11"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46213-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:02:52Z","timestamp":1779213772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46213-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46213"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46213-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not relevant. Additionally, neither human nor animal subjects are included in this study. The research does not require the personal information of patients. Every method was used in compliance with the relevant laws and guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study does not involve any human or animal subjects.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human research"}}],"article-number":"15581"}}